Likes
Bsv is a good company and hr policy is also good canteen facility very well enjoyment work .I like BSV from the heart
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
Panacea Biotec Quality Assurance Salary
1 - 20 years exp. (4 salaries) | ₹3 L/yr - ₹9 L/yr
101%
more | |
Biocon Limited Quality Assurance Salary
0 - 14 years exp. (5 salaries) | ₹2.5 L/yr - ₹12.6 L/yr
168%
more | |
Login to view exact salary
| ||
Zydus Lifesciences Quality Assurance Salary
0 - 18 years exp. (10 salaries) | ₹2.9 L/yr - ₹18.5 L/yr
289%
more | |
Cipla Quality Assurance Salary
0 - 9 years exp. (23 salaries) | ₹1.4 L/yr - ₹8.6 L/yr
74%
more | |
Sun Pharmaceutical Industries Quality Assurance Salary
2 - 13 years exp. (20 salaries) | ₹3.3 L/yr - ₹9 L/yr
140%
more | |
GlaxoSmithKline Pharmaceuticals Quality Assurance Salary
6 - 12 years exp. (3 salaries) | ₹9 L/yr - ₹12.3 L/yr
306%
more | |
Piramal Group Quality Assurance Salary
7 - 14 years exp. (5 salaries) | ₹6.7 L/yr - ₹8.5 L/yr
169%
more | |
Lupin Quality Assurance Salary
0 - 4 years exp. (13 salaries) | ₹1.2 L/yr - ₹4.2 L/yr
12%
less | |
Medreich Quality Assurance Salary
0 - 3 years exp. (7 salaries) | ₹2.6 L/yr - ₹4.2 L/yr
14%
more | |
Micro Labs Quality Assurance Salary
1 - 5 years exp. (6 salaries) | ₹2.9 L/yr - ₹4.5 L/yr
24%
more | |
Gland Pharma Quality Assurance Salary
0 - 2 years exp. (5 salaries) | ₹1 L/yr - ₹3.7 L/yr
21%
less | |
Login to view exact salary
| ||
Biological E Quality Assurance Salary
6 - 28 years exp. (5 salaries) | ₹5.5 L/yr - ₹8 L/yr
162%
more | |
Anthem Biosciences Quality Assurance Salary
0 - 4 years exp. (4 salaries) | ₹3.2 L/yr - ₹4.5 L/yr
49%
more | |
Apex Laboratories Quality Assurance Salary
1 - 2 years exp. (4 salaries) | ₹2 L/yr - ₹2.8 L/yr
16%
less | |
Global Calcium Quality Assurance Salary
0 - 5 years exp. (4 salaries) | ₹1.6 L/yr - ₹2.5 L/yr
20%
less | 2 job openings |
Hikal Quality Assurance Salary
4 - 8 years exp. (4 salaries) | ₹4.1 L/yr - ₹5.6 L/yr
79%
more | |
Discover interview dos and don'ts from real experiences
Top trending discussions